TY  - GEN
AU  - Merchante, Nicolás
AU  - Cárcel, Sheila
AU  - Garrido-Gracia, José Carlos
AU  - Trigo-Rodríguez, Marta
AU  - Moreno, María Ángeles Esteban
AU  - León-López, Rafael
AU  - Espíndola-Gómez, Reinaldo
AU  - Alonso, Eduardo Aguilar
AU  - García, David Vinuesa
AU  - Romero-Palacios, Alberto
AU  - Pérez-Camacho, Inés
AU  - Gutiérrez-Gutiérrez, Belén
AU  - Martínez-Marcos, Francisco Javier
AU  - Fernández-Roldán, Concepción
AU  - Pérez-Crespo, Pedro María Martínez
AU  - Caño, Alexandra Aceituno
AU  - León, Eva
AU  - Corzo, Juan E
AU  - de la Fuente, Carmen
AU  - Torre-Cisneros, Julián
PY  - 2021
DO  - 10.1128/AAC.02107-21
UR  - http://hdl.handle.net/20.500.12105/18517
AB  - The objective of this study was to investigate the efficacy and safety of early treatment with sarilumab, added to standard of care (SOC), in hospitalized adults with COVID-19. Methods included phase II, open-label, randomized, controlled clinical...
LA  - eng
KW  - SARS-CoV-2
KW  - Interleukin 6
KW  - Sarilumab
KW  - Tocilizumab
KW  - COVID-19
KW  - Adult
KW  - Antibodies, Monoclonal, Humanized
KW  - Humans
KW  - Inflammation
KW  - SARS-CoV-2
KW  - Treatment Outcome
KW  - COVID-19 Drug Treatment
TI  - Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial.
TY  - research article
ER  -